Sign in

CIK 0001819790 · Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
814717861
Phone
(949) 409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
  1. 4 Open-market sale Chief Human Resources Officer sold 6,711 shares at an average $47.88 ($321,323)
  2. 4 Open-market sale President/CEO and Board Chair sold 24,216 shares at an average $48.03 ($1,163,050)
  3. 4 Open-market sale See Remarks sold 3,724 shares at an average $47.88 ($178,306)
  4. 4 Option exercise See Remarks acquired 8,019 shares (option exercise)
  5. 4 Option exercise President/CEO and Board Chair acquired 51,395 shares (option exercise)
  6. 4 Option exercise Chief Human Resources Officer acquired 18,885 shares (option exercise)
  7. 4 Option exercise General Counsel acquired 19,213 shares (option exercise)
  8. 4 Option exercise Chief Operating Officer acquired 21,264 shares (option exercise)
  9. 4 Option exercise Chief Commercial Officer acquired 20,957 shares (option exercise)
  10. 4 Option exercise Director acquired 7,000 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 5 of 17 · 330 filings